Loading…
Based on limited metadata without access to the full warning letter text, this FDA enforcement action was issued to James Findling on December 31, 2019, regarding drug products. The specific violations cannot be detailed as no subject line information is available in the provided metadata. The warning letter falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in these records. Additional documentation would be needed to determine the exact nature of the compliance issues cited.